<DOC>
	<DOCNO>NCT00256399</DOCNO>
	<brief_summary>Uroxatral ( alfuzosin ) may help BPH symptom may also improve sexual function male BPH ED .</brief_summary>
	<brief_title>Uroxatral Men With Benign Prostate Hypertrophy ( BPH ) Erectile Dysfunction ( ED )</brief_title>
	<detailed_description>The study consist 30 day screening/washout phase end qualify subject assign alfuzosin 10 mg tablet day . Subjects treat 90 day . The total duration study 120 day .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>Males 4575 year age Confirmed diagnosis BPH/lower urinary tract symptom ( LUTS ) ED Men steady partner agree attempt sex week . Prostate cancer Prostatitis Penile disease Cardiac comorbidity Preexisting comorbid condition History sensitivity drug similar drug Enrollment another clinical trial Impaired hepatic function Impaired renal function Mental condition render subject unable understand study Subjects likely comply protocol</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>